-
-
-
-
-
-
-
Frequency Therapeutics Provides Business Updates and Fourth Quarter and Full Year 2022 Financial Results
-
-
-
-
-
-
-
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Frequency, DiDi, and CarLotz and Encourages Investors to Contact the Firm
-
-
-
-
-
-
-
Frequency Therapeutics (FREQ) PT Lowered to $12 at Goldman Sachs, Following Earnings
-
-
-
-
-
-
-
Frequency Therapeutics (FREQ) PT Raised to $31 at Goldman Sachs, Following Earnings
-
-
1,198,609 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

